Propofol increases pulmonary vascular resistance during α-adrenoreceptor activation in normal and monocrotaline-induced pulmonary hypertensive rats

Anesthesia and Analgesia

Volumn 104, Issue 1, 2007, Pages 112-118

  Edanaga, Mitsutaka ^a,b   Nakayama, Masayasu ^a   Kanaya, Noriaki ^a   Tohse, Noritsugu ^a   Namiki, Akiyoshi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; BISINDOLYLMALEIMIDE; CALPHOSTIN; INDOMETACIN; INTRALIPID; MARUISHI; MONOCROTALINE; N(G) NITROARGININE METHYL ESTER; PHENYLEPHRINE; PROPOFOL; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LUNG BLOOD VESSEL; LUNG PERFUSION; LUNG PRESSURE; LUNG VASCULAR RESISTANCE; LUNG VASOCONSTRICTION; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; RECEPTOR INTRINSIC ACTIVITY; SPRAGUE DAWLEY RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; LUNG CIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR RESISTANCE;

ANIMALS; HYPERTENSION, PULMONARY; MALE; MONOCROTALINE; PROPOFOL; PULMONARY CIRCULATION; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA; VASCULAR RESISTANCE;

EID: 33847671737     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000251200.14449.4a     Document Type: Article

References (24)

1. Yamanoue T, Brum JM, Estafanous FG. Vasodilation and mechanism of action of propofol in porcine coronary artery. Anesthesiology 1994;81:443-51.
2. Ogawa K, Tanaka S, Murray PA. Propofol potentiates phenylephrine-induced contraction via cyclooxygenase inhibition in pulmonary artery smooth muscle. Anesthesiology 2001;94:833-9.
3. Claeys MA, Gepts E, Camu F. Haemodynamic changes during anaesthesia induced and maintained with propofol. Br J Anaesth 1988;60:3-9.
4. Rich GF, Roos CM, Anderson SM, et al. Direct effects of intravenous anesthetics on pulmonary vascular resistance in the isolated rat lung. Anesth Analg 1994;78:961-6.
5. Kaye AD, Nossaman BD, Ibrahim IN, et al. Influence of protein kinase C inhibitors on vasoconstrictor responses in the pulmonary vascular bed of cat and rat. Am J Physiol 1995;268:L532-8.
6. Boer C, van der Linden PJ, Scheffer GJ, et al. RhoA/Rho kinase and nitric oxide modulate the agonist-induced pulmonary artery diameter response time. Am J Physiol Heart Circ Physiol 2002;282:H990-8.
7. LaBelle EF, Polyak E. Norepinephrine stimulates arachidonic acid release from vascular smooth muscle via activation of cPLA2. Am J Physiol 1998;274:C1129-37.
8. Nakazawa H, Hori M, Murata T, et al. Contribution of chloride channel activation to the elevated muscular tone of the pulmonary artery in monocrotaline-induced pulmonary hypertensive rats. Jpn J Pharmacol 2001;86:310-15.
9. Lennon PF, Murray PA. Pulmonary vascular effects of isoflurane anesthesia after left lung autotransplantation in chronically instrumented dogs. Anesthesiology 1996;85:592-9.
10. Nakayama M, Murray PA. Propofol selectively attenuates endothelium-dependent pulmonary vasodilation in chronically instrumented dogs. Anesthesiology 1999;91:760-71.
11. Toullec D, Pianetti P, Coste H, et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991;266:15771-81.
12. Kondo U, Kim SO, Nakayama M, Murray PA. Pulmonary vascular effects of propofol at baseline, during elevated vasomotor tone, and in response to sympathetic α- and β-adrenoreceptor activation. Anesthesiology 2001;94:815-23.
13. Park KW, Dai HB, Lowenstein E, Sellke FW. Propofol-associated dilation of rat distal coronary arteries is mediated by multiple substances, including endothelium-derived nitric oxide. Anesth Analg 1995;81:1191-6.
14. 2+ channel blocker. Anesth Analg 1993;76:24-32.
15. Smith WL. The eicosanoids and their biochemical mechanisms of action. Biochem J 1989;259:315-24.
16. Bao YP, Williamson G, Tew D, et al. Antioxidant effects of propofol in human hepatic microsomes: concentration effects and clinical relevance. Br J Anaesth 1998;81:584-9.
17. Agradi E, Petroni A, Socini A, Galli C. In vitro effects of synthetic antioxidants and vitamin E on arachidonic acid metabolism and thromboxane formation in human platelets and on platelet aggregation. Prostaglandins 1981;22:255-66.
18. Tyler RC, Muramatsu M, Abman SH, et al. Variable expression of endothelial NO synthase in three forms of rat pulmonary hypertension. Am J Physiol 1999;276:L297-L303.
19. Damron DS, Kanaya N, Homma Y, et al. Role of PKC, tyrosine kinases, and Rho kinase in α-adrenoreceptor-mediated PASM contraction. Am J Physiol Lung Cell Mol Physiol 2002;283:L1051-64.
20. 2+ transients and contraction in rat ventricular myocytes at supraclinical concentrations. Anesthesiology 1998;88:781-91.
21. Nakae Y, Fujita S, Namiki A. Propofol inhibits Ca(2+) transients but not contraction in intact beating guinea pig hearts. Anesth Analg 2000;90:1286-92.
22. Tanaka S, Kanaya N, Homma Y, et al. Propofol increases pulmonary artery smooth muscle myofilament calcium sensitivity: role of protein kinase C. Anesthesiology 2002;97:1557-66.
23. Ilkiw R, Maruyama K, Rabinovitch M. Intralipid effect on normal and hypoxic remodeled rat pulmonary vasculature. Am J Physiol 1988;255:H1499-508.
24. Theilen HJ, Adam S, Albrecht MD, Ragaller M. Propofol in a medium- and long-chain triglyceride emulsion: pharmacological characteristics and potential beneficial effects. Anesth Analg 2002;95:923-9.